Even worse, all that research money goes into a product which the company controls for only a set amount of years (before generics can be created) = so it can be very difficult to recoup costs (and the media will screech if they even try to do so).
There is little incentive in much of the world to do the R&D.
Not to mention that Europe steals US information in the medical journals about pharmaceuticals, in order to produce their own, which helps subsidize their public healthcare.